Search by Drug Name or NDC
NDC 25208-0002-03 AGGRASTAT 5 mg/100mL Details
AGGRASTAT 5 mg/100mL
AGGRASTAT is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Medicure International Inc. The primary component is TIROFIBAN HYDROCHLORIDE.
Product Information
| NDC | 25208-0002 |
|---|---|
| Product ID | 25208-002_09e14425-6dfb-40ba-8bf2-ba9cd28774d8 |
| Associated GPIs | 85153060112010 85153060112015 |
| GCN Sequence Number | 064721 |
| GCN Sequence Number Description | tirofiban-0.9% sodium chloride PLAST. BAG 5 MG/100ML INTRAVEN |
| HIC3 | M9P |
| HIC3 Description | PLATELET AGGREGATION INHIBITORS |
| GCN | 16188 |
| HICL Sequence Number | 018384 |
| HICL Sequence Number Description | TIROFIBAN HCL MONOHYDRATE IN 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Brand |
| Proprietary Name | AGGRASTAT |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | TIROFIBAN |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/100mL |
| Substance Name | TIROFIBAN HYDROCHLORIDE |
| Labeler Name | Medicure International Inc |
| Pharmaceutical Class | Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020913 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25208-0002-03 (25208000203)
| NDC Package Code | 25208-002-03 |
|---|---|
| Billing NDC | 25208000203 |
| Package | 1 VIAL, GLASS in 1 CARTON (25208-002-03) / 100 mL in 1 VIAL, GLASS |
| Marketing Start Date | 2016-10-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |